阿斯利康

#8M: Un Mes para Reflexionar y Actuar por la Igualdad de Género En AstraZeneca Cono Sur, la igualdad de género no es solo una aspiración, es un principio que impulsa nuestras acciones y define nuestra cultura. Este marzo, en el marco del Día Internacional de la Mujer, renovamos nuestro compromiso de avanzar hacia un futuro más inclusivo y equitativo. Realizamos una charla inspiradora que contó con la moderación de Ana Belén Anglesio y la presencia de líderes como Leticia Murray, Martha Segovia, @Verónica Correa y @Adriana Cu?etti Betancurt, en la que se generó un interesante intercambio con todos los asistentes y un valioso espacio para reflexionar sobre los logros alcanzados y los desafíos pendientes en materia de género. Como resaltó Leticia Murray, Presidenta de AstraZeneca Cono Sur,?“la igualdad de género debe ser la norma, no la excepción”.?Su mensaje nos impulsa a actuar unidos por un cambio cultural sostenido. ???El cambio empieza desde uno:?reflexiona sobre cómo puedes aportar desde tu entorno a un mundo más equitativo. ???? #IgualdadDeGénero #Diversidad #Inclusión #8M #AstraZenecaConoSur CóDIGO PROMOMATS:?XC-0407

Following our recent announcement to invest in a new strategic R&D centre in Beijing, our CEO Pascal Soriot and Iskra Reic, Executive Vice President for International, joined global leaders at the China Development Forum in Beijing and the Boao Forum for Asia in Hainan. Discussions focused on embracing scientific innovations in Asia through strong collaboration to tackle global healthcare challenges and advance shared sustainability goals for people, society, and the planet. #WhatScienceCanDo #CDF2025 #BoaoForum2025

#Sustainability is at the heart of everything we do. We’re delighted to align with the NHS’s long-term sustainability priorities, working towards a healthier future. With independently validated 2045 net-zero targets, we have reduced our Scope 1 (fuel combustion and facility operations) and Scope 2 (electricity, heat, and steam) emissions by 77.5% as of the end of 2024. We remain on track to achieve our 98% reduction target by 2026. Learn more about how we’re driving change: https://lnkd.in/eFY9cm3B

Every day, we’re deepening our understanding of the interconnections between cardiovascular, renal and metabolic (CVRM) diseases. We’re advancing the science to add new therapies to our innovative pipeline, designed not only to target individual conditions but to address the complex nature of CVRM conditions. This approach ensures we treat the whole patient—improving both health and overall quality of life. Our research goes beyond isolated conditions, offering holistic solutions to help people living with CVRM diseases live healthier lives. Learn more: https://bit.ly/4hFuimE #ACC25

Too many patients still face health risks from treatment-resistant hypertension, high LDL-cholesterol and amyloidosis. These are persistent challenges that continue to drive the growing burden of cardiovascular, renal and metabolic (CVRM) diseases, despite significant advances in medical care. Tackling these risk factors is essential to help reduce disease burden and improve patient outcomes. Learn more about the ways we are pushing the boundaries to innovate and transform CVRM care: https://learn.az/6048FEPyg #ACC25

Join ??????????????????????'?? ???????????? ???????????????????? ?????? ???????????????????? ???????????? (????????) ???? ?????????????? and be part of a team that's revolutionising global healthcare.? We're reshaping the way we manage resources, forecast demand and streamline production through smarter planning systems and real-time, data-driven insights.? Hear what Arun Krishnan, Vice President - Planning, Global Supply Chain, has to say about the exciting opportunities in AstraZeneca and how you can make an impact. As a key member of our Global Supply Chain & Strategy and External Supply & Manufacturing teams, you'll play a vital role in delivering life-changing medicines to patients worldwide — efficiently and sustainably. One such opportunity is the Network Supply Planner role, where you'll create and maintain cross-brand production and capacity plans, driving essential processes like Sales & Operations Execution (S&OE). Collaborating with internal and external stakeholders, you'll optimise supply and help shape the future of supply chain management. If you're passionate about technology, AI and advancing the future of supply chain, we'd love to hear from you! Learn more and apply here: https://lnkd.in/gMamWS2M ? #AstraZenecaCareers #InnovationInHealthcare #SupplyChainExcellence?

#AstraZenecaThailand is delighted to announce the signing of a Memorandum of Understanding (MoU) with Banphaeo Hospital, marking a significant step forward in advancing clinical research in Thailand. Our initial collaboration, which began in May 2024, has expanded to encompass five clinical studies across Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology, and our mission to strengthen public health continues. This collaboration paves the way for fostering an environment of shared knowledge and innovation, enhancing access to innovative medical treatments, and building a healthier community for the Thai people. #AstraZeneca #WhatScienceCanDo

?????????????????? ?????? ??????! ???????????? ??????????????????-??????????????????????:?????????? ???? ?????????????????? ??? Weiter geht’s mit Anna Maria Katschnig, PhD, Diagnostic Manager Oncology, die eindrucksvoll erz?hlt, warum es so wichtig ist, in frühzeitige Diagnosen und das Gesundheitssystem zu investieren, und unsere Rolle in der Verbesserung der gesundheitlichen Versorgung hervorhebt. ?? Wollen Sie auch Teil unseres Teams werden? Dann bewerben Sie sich jetzt! Gemeinsam k?nnen wir Gro?es bewegen. https://lnkd.in/eivt5WUZ #AstraZenecaAustria #MenschenMutMedizin #OnkologieMitMut #ZusammenWachsen #WorkAtAZ #GreatPlaceToWork

It’s day one at #ELCC25 and we’re showcasing new data that underscores the power of novel combinations to drive deeper, more durable responses across lung cancer stages and settings. Collaboration with the scientific community is critical to advancing care. Dr. Pasi Janne shares why combination therapies are bringing us closer to one day eliminating cancer, including lung cancer, as a cause of death.

Congratulations to Katy Miller, Puja Sapra and Tiffany Day Davis on their recent awards from the Healthcare Businesswomen’s Association. Tiffany Davis has been honoured as a Rising Star for her remarkable efforts within AstraZeneca and her advocacy for equity in the industry. Additionally, Katy Miller and Puja Sapra have been recognized as HBA Luminaries for their significant impact on advancing women's careers and their dedication to healthcare. #WhatScienceCanDo #HBAimpact #HBAWOTY25